Laboratory-confirmed case of middle east respiratory syndrome coronavirus (MERS-COV) infection in Malaysia: Preparedness and response, April 2014

Eurosurveillance

Volumn 19, Issue 18, 2014, Pages

  Premila Devi, J ^a   Noraini, W ^a   Norhayati, R ^a   Chee Kheong, C ^a   Badrul, A S ^a   Zainah, S ^a   Fadzilah, K ^a   Hirman, I ^a   Lokman Hakim, S ^a   Noor Hisham, A ^a  

^a MINISTRY OF HEALTH   (Malaysia)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CORONAVIRUS INFECTION; DISEASE ASSOCIATION; HOSPITALIZATION; HUMAN; LABORATORY TEST; LUNG DISEASE; MALE; MICROBIOLOGICAL EXAMINATION; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME; PNEUMONIA; POLYMERASE CHAIN REACTION; RESPIRATORY DISTRESS;

ANTIVIRAL AGENTS; COMMUNICABLE DISEASE CONTROL; CONTACT TRACING; CORONAVIRUS; CORONAVIRUS INFECTIONS; DISEASE NOTIFICATION; FATAL OUTCOME; HUMANS; MALAYSIA; MIDDLE AGED; OSELTAMIVIR; POLYMERASE CHAIN REACTION; POPULATION SURVEILLANCE; RESPIRATORY TRACT INFECTIONS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SAUDI ARABIA; SYNDROME; TRAVEL;

EID: 84900405344     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/1560-7917.ES2014.19.18.20797     Document Type: Article

References (17)

1. Ministry of Health Malaysia. Policies and procedures of infection control. 2nd edition. Putrajaya: Ministry of Health Malaysia; 2010. Available from: http://www.moh.gov.my/images/gallery/Polisi/infection_control.pdf
2. World Health Organization (WHO). Laboratory Testing for Middle East Respiratory Syndrome Coronavirus. Geneva: WHO; Sep 2013. Available from:http://www.who.int/csr/disease/coronavirus_infections/MERS_Lab_recos_16_Sept_2013.pdf?ua=1
3. World Health Organization (WHO). Middle East Respiratory Syndrome Coronavirus (MERS-CoV). Initial Interview Questionnaire of Cases. Guide for the interviewer. Geneva: WHO. [Accessed 05 May 2014]. Available from:http://www.who.int/csr/disease/coronavirus_infections/MERS_case_investigation_questionnaire.pdf
4. Danielsson N, on behalf of the ECDC Internal Response Team, Catchpole M. Novel coronavirus associated with severe respiratory disease: Case definition and public health measures. Euro Surveill. 2012;17(39):pii=20282.
5. Zaki AM, van Boheemen S, Bestebroer TM, Osterhaus AD, Fouchier RA. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. N Engl J Med. 367(19):1814-20. http://dx.doi.org/10.1056/NEJMoa1211721
6. Hijawi B, Abdallat M, Sayaydeh A, Alqasrawi S, Haddadin A, Jaarour N et al. Novel coronavirus infections in Jordan, April 2012: epidemiological findings from a retrospective investigation. East Mediterr Health J. 2013; 19 Suppl 1:S12-8.
7. World Health Organization (WHO). WHO risk assessment: Middle East respiratory syndrome coronavirus (MERS-CoV). 24 April 2014. Geneva: WHO; Apr 2014. Available from:http://www.who.int/csr/disease/coronavirus_infections/MERS_CoV_RA_20140424.pdf?ua=1
8. World Health Organization (WHO). Revised interim case definition for reporting to WHO-Middle East respiratory Syndrome coronovirus (MERS-CoV). Interim case definitions as of 3 July 2013. Geneva: WHO. [Accessed 05 May 2014]. Available from: http://www.who.int/csr/disease/coronavirus_infections/case_definition/en/
9. Ministry of Health, Malaysia. Makluman StatusTerkini Mengenai Kejadian Jangkitan MERS-CoV Dan Langkah Kesiapsiagaan Kementerian Kesihatan Malaysia (BIL. 02/2013) [Accessed 05 May 2014]. Malaysian. Available from:http://htan.moh.gov.my/v1/htdocs/Makluman%20Status%20Terkini%20Mengenai%20Kejadian%20Jangkitan%20MERS-CoV%20Bil.%2002_2013%20(Ogos%202013).pdf
10. Ministry of Health Malaysia. Malaysia Influenza Surveillance System (M.I.S. S): Clinical and Laboratory Surveillance. Putrajaya: Ministry of Health Malaysia; Sep 2004, Available from:http://h1n1.moh.gov.my/NIPPP/MISS%20-Clinical%20Lab%20Surveillance.pdf
11. Assiri A, Al-Tawfiq JA, Al-Rabeeah AA, Al-Rabiah FA, Al-Hajjar S, Al-Barrak A, et al. Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study. Lancet Infect Dis. 2013;13(9):752-61. http://dx.doi.org/10.1016/S1473-3099(13)70204-4
12. Assiri A, McGeer A, Perl TM, Price CS, Al Rabeeah AA, Cummings DA, et al. Hospital outbreak of Middle East respiratory syndrome coronavirus. N Engl J Med. 2013;369(5):407-16. http://dx.doi.org/10.1056/NEJMoa1306742
13. European Centre for Disease Prevention and Control (ECDC). Updated rapid risk assessment. Severe respiratory disease associated with Middle East respiratory syndrome coronavirus (MERS-CoV), Ninth update, 24 April 2014. Stockholm: ECDC; Apr 2014. Available from:http://www.ecdc.europa.eu/en/publications/Publications/Middle-East-respiratory-syndrome-coronavirus-risk-assessment-25-April-2014.pdf
14. Reusken CB, Haagmans BL, Müller MA, Gutierrez C, Godeke GJ, Meyer B, et al. Middle East respiratory syndrome coronavirus neutralising serum antibodies in dromedary camels: a comparative serological study. Lancet Infect Dis. 2013;13(10):859-66. http://dx.doi.org/10.1016/S1473-3099(13)70164-6
15. Perera RA, Wang P, Gomaa MR, El-Shesheny R, Kandeil A, Bagato O, et al. Seroepidemiology for MERS coronavirus using microneutralisation and pseudoparticle virus neutralisation assays reveal a high prevalence of antibody in dromedary camels in Egypt, June 2013. Euro Surveill. 2013;18(36):pii=20574. http://dx.doi.org/10.2807/1560-7917.ES2013.18.36.20574
16. Nowotny N, Kolodziejek J. Middle East respiratory syndrome coronavirus (MERS-CoV) in dromedary camels, Oman, 2013. Euro Surveill. 2014;19(16):pii=20781. http://dx.doi.org/10.2807/1560-7917.ES2014.19.16.20781
17. van Doremalen N, Bushmaker T, Karesh WB, Munster VJ. Stability of Middle East respiratory syndrome coronavirus in milk [letter]. Emerg Infect Dis. 2014;20(7). [Epub ahead of print]. http://dx.doi.org/10.3201/eid2007.140500